Literature DB >> 429290

Bilirubin. Solubility and interaction with albumin and phospholipid.

R Brodersen.   

Abstract

Bilirubin is generally considered a lipophilic substance, and its neurotoxicity is ascribed to an affinity for lipids in the central nervous system. In the present paper, it is shown that the solubility of bilirubin in apolar solvents and in triglycerides is low and increases with solvent polarity. Consequently, bilirubin should not be characterized as lipophilic. The solubility in aqueous buffers was studied under exclusion of light and was found lower than previously reported, about 7 nM at pH 7.4, temperature 37 degrees C, increasing with higher pH, approximately in inverse proportion with the squared hydrogen ion concentration. Binding of bilirubin to human serum albumin was studied by the rate of oxidation with peroxidase of the free ligand at equilibrium. The stoichiometry of proton involvement in the binding process was investigated by acidimetric titration. It is concluded that precipitation of bilirubin in vivo is thermodynamically possible. It was further demonstrated by light absorption spectroscopy that bilirubin forms a complex with phosphatidylcholine in diethyl ether and that an aqueous suspension of phosphatidylcholine enhanced aggregation of bilirubin. Transfer of bilirubin dianion from its complex with plasma albumin and precipitation of bilirubin acid with phosphatidylcholine in membranes of nerve cells is therefore possible and may account for the neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429290

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease.

Authors:  Kevin A Strauss; Donna L Robinson; Hendrik J Vreman; Erik G Puffenberger; Graham Hart; D Holmes Morton
Journal:  Eur J Pediatr       Date:  2006-01-25       Impact factor: 3.183

4.  Uptake of bilirubin glucuronides by isolated rat hepatocytes.

Authors:  Y Adachi; R Kinne; J R Chowdhury; N R Chowdhury; L Theilmann; T Tran; I M Arias
Journal:  Gastroenterol Jpn       Date:  1991-06

5.  Ligand-binding properties of proalbumin Christchurch.

Authors:  R G Reed; T Peters; S O Brennan; R W Carrell
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

6.  Ampicillin inhibits biliary cholesterol secretion.

Authors:  M D Apstein; A R Russo
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

Review 7.  Review: Bilirubin pKa studies: new models and theories indicate high pKa values in water, dimethylformamide and DMSO.

Authors:  Pasupati Mukerjee; J Donald Ostrow
Journal:  BMC Biochem       Date:  2010-03-29       Impact factor: 4.059

Review 8.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

9.  Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.

Authors:  I Muraoka; T Hasegawa; M Nadai; L Wang; S Haghgoo; O Tagaya; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Non-enzymic hydrolysis of bilirubin mono- and diglucuronide to unconjugated bilirubin in model and native bile systems. Potential role in the formation of gallstones.

Authors:  W Spivak; D DiVenuto; W Yuey
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.